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Abstract 
Background: Parvalbumin (PV) is a calcium binding protein that identifies a subpopulation of proprioceptive dorsal 
root ganglion (DRG) neurons. Calcitonin gene-related peptide (CGRP) is also expressed in a high proportion of muscle 
afferents but its relationship to PV is unclear. Little is known of the phenotypic responses of muscle afferents to nerve 
injury. Sciatic nerve axotomy or L5 spinal nerve ligation and section (SNL) lesions were used to explore these issues in 
adult rats using immunocytochemistry.
Results: In naive animals, the mean PV expression was 25 % of L4 or L5 dorsal root ganglion (DRG) neurons, and this 
was unchanged 2 weeks after sciatic nerve axotomy. Colocalization studies with the injury marker activating tran-
scription factor 3 (ATF3) showed that approximately 24 % of PV neurons expressed ATF3 after sciatic nerve axotomy 
suggesting that PV may show a phenotypic switch from injured to uninjured neurons. This possibility was further 
assessed using the spinal nerve ligation (SNL) injury model where injured and uninjured neurons are located in differ-
ent DRGs. Two weeks after L5 SNL there was no change in total PV staining and essentially all L5 PV neurons expressed 
ATF3. Additionally, there was no increase in PV-ir in the adjacent uninjured L4 DRG cells. Co-labelling of DRG neurons 
revealed that less than 2 % of PV neurons normally expressed CGRP and no colocalization was seen after injury.
Conclusion: These experiments clearly show that axotomy does not produce down regulation of PV protein in the 
DRG. Moreover, this lack of change is not due to a phenotypic switch in PV immunoreactive (ir) neurons, or de novo 
expression of PV-ir in uninjured neurons after nerve injury. These results further illustrate differences that occur when 
muscle afferents are injured as compared to cutaneous afferents.
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Background
Peripheral nerve injury disconnects sensory and motor 
axons from their peripheral targets and results in the 
production of regeneration associated genes such as 
α-tubulin, GAP43, CAP23, ATF3, and STAT3 that are 
important in the growth and functional recovery of dam-
aged sensory and motor axons [1, 2]. Primary sensory 
neurons also show considerable plasticity when subjected 
to peripheral nerve injury. For example, directly injured 
neurons can upregulate neurotransmitters such as NPY, 
BDNF, galanin whilst adjacent uninjured neurons can 
increase their content of neurotransmitters such as sub-
stance P, CGRP, BDNF, galanin and ion channels such 
as TRPRV1 and P2X3 [3–5]. This plasticity is thought 
to contribute to the generation and maintenance of neu-
ropathic pain [3, 6, 7]. However, the mechanisms that 
contribute to chronic pain syndromes are incompletely 
understood. Several different models have been devel-
oped to explore the contributions of primary afferents to 
chronic pain syndromes [3, 8, 9]. Most models employ 
injury to the sciatic nerve, a mixed peripheral nerve, or 
its branches. Interestingly, one study demonstrates the 
importance of muscle afferents to the pathobiology of 
nerve injury pain. When the gastrocnemius (muscle) or 
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tibial (mixed) or sural (cutaneous) nerve was sectioned, 
mechanical and thermal hypersensitivity only occurred 
in nerve injuries involving muscle afferents [10].
The phenotypic responses of muscle afferents to nerve 
injury have been relatively little studied. In the DRG, 
muscle afferents are generally identified by their size, 
neurotrophic factor dependence, or their expression of 
particular neurotransmitters or proteins [11–18]. Retro-
grade tracing experiments show that muscle afferents are 
both myelinated and unmyelinated [16]. Muscle nocic-
eptors are generally small and contain high levels of the 
neuropeptide CGRP [15, 16] whereas muscle spindle 
afferents are generally large-sized, myelinated fibres that 
express carbonic anhydrase, or the calcium binding pro-
teins calretinin, calbindin, neurocalcin or parvalbumin 
[19–25]. Some of these markers, however, are not specific 
to muscle afferents, as they are also found in skin affer-
ents [26–28]. Whilst parvalbumin is generally regarded 
as a reliable marker for proprioceptive afferents [22, 23], 
genetic studies have revealed that, by itself, it is not a 
selective marker of muscle proprioceptors nor a marker 
of muscle afferent nociceptors [26, 29].
Relatively few studies have assessed the effects of nerve 
injury on parvalbumin expression. Most of the published 
literature concerns injuries to branches of the trigemi-
nal [30, 31] or sciatic [22, 32, 33] nerves and the gen-
eral consensus appears to be that injury has little effect 
on parvalbumin expression in the affected DRGs. One 
possible reason for this is that a phenotypic change in 
expression in injured versus uninjured afferents occurs, 
such that parvalbumin expression is decreased in injured 
neurons and increased in uninjured neurons. As the sci-
atic nerve contains axons originating in the L4-6 DRGs, 
afferents from these ganglia are only partially affected 
by peripheral nerve injury. By assessing changes only in 
parvalbumin expression with this model it is not pos-
sible to tell whether a phenotypic change has occurred. 
Phenotypic switching in primary afferents is known to 
occur in nerve injury models [3, 5, 34]. This issue can be 
explored by using the regeneration associated transcrip-
tion factor ATF3 [35]. ATF3 is not expressed in the DRG 
nuclei of uninjured neurons but is rapidly induced in all 
injured neurons following peripheral axotomy or spinal 
nerve injury [35]. By quantitatively assessing the number 
of co-labelled ATF3 and parvalbumin neurons after sci-
atic nerve injury, it is possible to determine the presence 
or absence of a phenotypic switch. A second, and more 
clear-cut, method involves using a spinal nerve ligation 
and section injury [36]. This essentially injures all axons 
in the L5 DRG but leaves axons in the adjacent L4 DRG 
largely unaffected [5, 34, 35]. Changes can then be com-
pared by assessing the numbers of PV cells in the two 
adjacent ganglia.
Therefore, the aim of this study is to test the hypothesis 
that peripheral nerve injury induces a phenotypic switch 




PV-ir was expressed primarily in medium to large-sized 
DRG neurons (Fig.  1a). Quantification of expression in 
the L4 and L5 ganglia is shown in Table  1. Similar per-
centages were expressed in both ganglia and there was 
no statistical difference between the ganglia (t7 = 0.255, 
P > 0.5, 2-tailed test).
CGRP-ir was predominantly expressed in small-sized 
DRG neurons with some expression in medium- and 
large-sized DRGs (Fig.  1b). Quantification of CGRP-
ir expression in the naive L5 ganglia was 48.3  ±  1.9  % 
(N  =  6). Colocalisation between PV-ir and CGRP-
ir within the L5 DRG was negligible (1.9 ±  1.9  %) and, 
when present, was restricted to the large-sized neurons.
Sciatic nerve axotomy
The expression of PV-ir in the L4 and L5 ganglia 2 weeks 
after sciatic nerve axotomy is detailed in Table 1. The per-
centage expression in these ganglia was not significantly 
different from naïve ganglia (L5 DRG: F2,11  =  1.800, 
P > 0.1, L4 DRG: t7 =  0.766, P > 0.5, 2-tailed test). The 
PV-ir in axotomised neurons was observed in the 
medium to large-sized cells of the ganglia, identical to 
that seen in naive ganglia.
It is possible that the unchanged percentage of PV-ir 
after sciatic nerve axotomy reflects a phenotypic switch 
in neurons such that injured neurons lose immunoreac-
tivity and uninjured ones start to express PV de novo. To 
explore this possibility colocalisation with ATF3 was per-
formed (Fig. 2). ATF3-ir was expressed in 50.7 % ± 4.9 of 
ipsilateral L5 DRG and 43.4 % ± 7.0 of the ipsilateral L4 
ganglion cells, and these values were was not significantly 
different from each other (p = 0.21).
If a phenotypic switch occurs, one might expect to see 
little or no colocalisation with ATF3 after injury. How-
ever, this was not the case (Fig.  2). Analysis of double 
labelled sections showed that 23.7 % ± 3.7 of PV-ir cells 
(range 16–30 %) expressed ATF3 in the injured ipsilateral 
L4-5 ganglia. By itself, this result is insufficient to deter-
mine if a phentotypic switch is occurring.
Spinal nerve ligation
To better explore the possibility of a phenotypic switch 
after injury, the experiment was repeated using the L5 
spinal nerve injury model, which essentially damages all 
of the axons of the L5 ganglion neurons whilst leaving 
most of the axons of the adjacent L4 DRG intact [5, 34].
Page 3 of 10Medici and Shortland  BMC Neurosci  (2015) 16:93 
The L4 and L5 ganglia from both ipsilateral and con-
tralateral sides to the L5 SNL were stained (Fig.  3) and 
quantified for immunoreactivity to PV, ATF3, and CGRP 
(Table 2). The mean percentage expression of PV-ir in the 
ipsilateral injured L5 ganglia was not significantly differ-
ent from naive animals (F1,8 = 0.266, P > 0.5) or the con-
tralateral side (F1,8 = 2.126, P > 0.1) or the ipsilateral L4 
DRG (F1,8 = 0.103, P > 0.5).
ATF3-ir in the contralateral L5 DRG was negligible 
(Table  2). In the injured L5 ganglia, ATF3-ir was found 
in almost all cells (Fig.  3), confirming the completeness 
of the lesion. Essentially, nearly all PV-ir neurons coex-
pressed ATF3 (Table 2). In the ipsilateral L4 ganglia the 
average ATF3-ir was low (Table 2) but significantly more 
than the contralateral side (F1,6 = 7.242, P = 0.036), with 
the occasional PV-IR cell showing ATF3 staining (Fig. 3).
CGRP staining was essentially absent from the L5 
DRG neurons in the injured ganglion, although some 
axonal staining could be detected (Fig. 4). The character-
istic punctate staining in the cell cytoplasm that is nor-
mally present (Fig. 4b) is absent in the ipsilateral L5 DRG 
(Fig. 4a). In the ipsilateral L4 ganglia the average CGRP-
ir was not significantly different from naïve animals 
(Table  2; p  >  0.5) and colocalisation of CGRP in PV-ir 
cells was 0.6 ± 0.3 %.
Discussion
PV is often used as a marker of a subpopulation of (mus-
cle) proprioceptive afferents, comprising 10–33 % of cells 
in spinal and trigeminal ganglia [11, 19, 22, 23, 33, 37, 38]. 
This study found that 25 % of naïve rat L4-5 DRGs were 
PV-ir, consistent with these earlier reports. By itself, PV 
is not an exclusive marker of muscle proprioceptive affer-
ents, as it is also expressed in Pacinian corpuscles, Mer-
kel cells and lanceolate endings of cutaneous afferents 
[26]. Thus, since retrograde tracing from muscles was not 
used in this study we cannot be sure that all PV-ir cells 
in this study are muscle proprioceptors. However, only 
around 1.5  % of L4-5 PV-ir DRG cells arise from skin 
afferents [22] and a recent anatomical study showed that 
27  % of lumbar dorsal root fibres were positive for α3 
Na+/K+  ATPase, a specific marker of muscle afferents 
[13]. The similarity in percentage expression of PV-ir and 
α3 Na+/K+  ATPase implies that PV-ir afferents should 
express this ATPase transporter, although this awaits 
confirmation. Together, these suggest that the vast major-
ity of PV-ir cells are muscle proprioceptors.
Whilst PV is almost exclusively expressed in large 
diameter muscle afferents [22], CGRP is expressed in 
both large and small diameter muscle afferents [16]. 
The large-sized neurons correspond to the group I-II 
muscle spindle and Golgi tendon organ (propriocep-
tive) afferents, whereas group III-IV afferents are small 
diameter muscle afferents associated with muscle meta-
bolic responses, blood vessel innervation, sensations 
involved during exercise and muscle pain [39]. Colo-
calisation studies suggest that PV is found in DRGs that 
may also contain calbindin, carbonic anhydrase (CA) and 
cytochrome oxidase [11, 20]. This is consistent with the 
proposed role of PV in facilitation of fast, repeated, affer-
ent firing of fast twitch muscles [40, 41]. CGRP is also 
expressed in large-sized DRG cells but the colocalisation 
of PV and CGRP was minimal in the present study, con-
firming earlier studies [23, 42].
Plasticity of primary afferents after injury
DRG cells show considerable plasticity in response to 
peripheral nerve injury. Following injury, peptides such 
Fig. 1 An example of parvalbumin and CGRP staining in naïve L5 DRG. a shows PV-ir (green), b shows CGRP-ir (red) staining and c is the merged 
image showing essentially no overlap between these populations. Scale bar 100 μm
Table 1 Percentage expression of  parvalbumin in  L4 
and L5 DRGs in naïve and sciatic axotomy groups
L4 DRG L5 DRG
Naïve (N = 6) 25.7 % ± 1.8 25.1 % ± 1.8
2 week sciatic nerve axotomy (N = 5) 23.1 % ± 1.9 21.7 % ± 1.5
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as CGRP and substance P are often down regulated in 
injured DRGs whilst other peptides such as galanin and 
neuropeptide Y are upregulated (reviewed by [4, 6]). This 
de novo expression also occurs in adjacent uninjured 
DRGs [3].Only a few studies have assessed the effects of 
axotomy on PV afferents and these have largely been in 
the trigeminal system [31, 43, 44]. The trigeminal sys-
tem is different from the spinal system in that PV-ir is 
expressed in both the trigeminal ganglion (Vg), which 
contains cell bodies of cutaneous afferents and the mes-
encephalic nucleus (Vmes), which contains cell bodies of 
muscle afferents. When the inferior alveolar nerve was 
sectioned no change in PV numbers occurred in the Vg 
[31]. When the masseter nerve was sectioned there was 
a significant drop in PV-ir cells in Vmes between 4 and 
14 days post injury [43]. However, as there was no base-
line control values for PV-ir in Vmes, there is no certainty 
as to whether there was an overall decrease in expression 
Fig. 2 Parvalbumin (green) and ATF3 (red) staining in the ipsilateral L4 (A, C, E) and L5 (B, D, F) ganglia of rats with sciatic nerve axotomy 2 weeks 
previously. Arrows indicate double-labelled cells, whilst arrowheads denote cells only expressing ATF3. Both injured and uninjured cells express PV-ir. 
Scale bar 75 μm
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by day 14 or whether there was an increase which nor-
malised by day 14. Alternatively, since PV is expressed in 
periodontal ligament afferents in the Vg [44], the differ-
ence between the two studies may reflect a difference in 
the response to injury of cutaneous mechanoreceptors 
versus muscle afferents.
In spinal DRGs, previous injury studies suggest that 
PV numbers either did not change [22] or were tran-
siently decreased [32]. These studies were at early 
Fig. 3 Parvalbumin (green) and ATF3 (red) staining in the ipsilateral L4 (A, C, E) and L5 (B, D, F) ganglia 2 weeks after L5 spinal nerve ligation and 
section. Arrows denote examples of double-labelled cells; arrowheads denote examples of cells that only express ATF3. Almost all PV-ir cells were 
ATF3-ir in the L5 ganglion (arrows). Very few ATF3 cells were seen in L4 DRG. Scale bar 75 μm
Table 2 Effects of  L5 spinal nerve ligation on  percentage 
expression of  different neurochemical parameters in  the 
L4-5 DRG neurons 2 weeks after injury
(N = 5) L4 DRG  
ipsilateral
L5 DRG  
ipsilateral
L5 DRG  
contralateral
Parvalbumin 23.0 % ± 1.2 22.8 % ± 0.9 22.2 % ± 0.8
CGRP 44.5 % ± 1.7 0 48.3 % ± 2.7
ATF3 2.8 % ± 0.9 92.8 % ± 0.9 0.3 % ± 0.1
Page 6 of 10Medici and Shortland  BMC Neurosci  (2015) 16:93 
time-points when changes in neurochemical phenotype 
are only beginning to start [45]. Additionally, these pre-
vious studies did not consider the possibility of a phe-
notypic switch between injured and uninjured neuronal 
populations [3, 34]. This study examined changes at 
only 1 time point, 2 weeks after injury. Whilst it is pos-
sible that changes occurred before then, previous studies 
have shown that peak changes in DRG neurotransmit-
ter staining occur at 2 weeks post injury [4, 46]. Moreo-
ver, the percentage expression of ATF3 positive injured 
neurons remains unchanged over the first month after 
both types of nerve injury [5, 47]. Therefore, analys-
ing co-labelling at this time point should maximise the 
changes of observing any differences as a result of injury. 
By using the SNL model and co-labelling ATF3 with PV, 
this study unequivocally showed that injury did not pro-
duce a phenotypic switch in PV staining from injured to 
uninjured neurons, and that PV-ir in DRGs is not regu-
lated by nerve injury. This contrasts with small diameter 
neurons, whose phenotype changes with nerve injury 
due to the loss of target derived trophic factors like NGF 
and BDNF [46].
These results are also consistent with the lack of change 
of other markers in large-sized DRG neurons after 
injury: NF200, a marker of large myelinated afferents, is 
unchanged [45, 46] and α3 Na+/K+ ATPase is reported 
not to change in spinal nerve injury up to 1  week post 
injury [17]. Neuronal p75 levels in muscle afferents are 
unchanged after injury [48] as is TRPV2 expression [49]; 
TRPV2 has been shown to be colocalised to some muscle 
afferents [50]. CA, which is also localised to muscle pro-
prioceptive afferents, also shows no change in expression 
after sciatic nerve injury [51]. Lastly, the lectin soybean 
agglutinin (SBA) is unchanged after injury for at least 
3  months in the DRG [52]. SBA is expressed in about 
50 % of small- and medium-sized muscle DRG cells [18] 
and is extensively co-expressed with CGRP but not CA 
[53]. It is possible that PV levels may decline later on, in 
a fashion similar to SBA and CA, but further studies are 
required to verify this; however, we see no change in PV 
expression at 4 weeks after sciatic injury (Shortland and 
Medici, unpublished observations).
Does this mean that large-sized, presumed, muscle 
proprioceptive afferents are incapable of phenotypic plas-
ticity? Evidence suggests that at least some medium-large 
diameter muscle afferents upregulate NPY and galanin 
and BDNF [10, 54, 55]. Indeed, Zhou et al. [10] demon-
strated that BDNF was increased in axotomised muscle 
but not skin afferents and this was critical to produce 
neuropathic pain. Most recently, Fukuoka et al. [56] have 
demonstrated an increase in Nav1.7 in axotomised puta-
tive proprioceptors in DRGs and the gracile nucleus fol-
lowing spinal nerve ligation. Taken together, these studies 
suggest that different neurotransmitters and receptors 
may be differentially regulated within single cells. CGRP 
and substance P have also been reported to increase in 
large sized DRG neurons [57, 58]. Whilst mRNA lev-
els have confirmed this, protein expression studies have 
been less convincing. The majority of studies examining 
SP or CGRP-IR changes in the axotomised DRG have 
used immunofluorescence cytochemistry [5, 45, 59] and 
failed to confirm the earlier reports based on mRNA or 
DAB histochemistry, suggesting differential sensitivity 
based on methodology. In this study, CGRP-ir was almost 
completely depleted in the L5 DRG somas after spinal 
nerve injury, and even if a few large cells increase CGRP 
protein expression these results suggest it is not in PV-ir 
afferents.
Fig. 4 An example of ATF3 and CGRP staining in L5 DRGs 2 weeks after spinal nerve section. a L5i ganglion showing no CGRPr in ATF3 positive 
cells. CGRP axons were visible in the tissue (arrows) but the characteristic punctate staining in the cell cytoplasm is absent. b Contralateral ganglion 
showing many CGRP-ir cells (arrows). The curved arrow shows an example of an ATF3+/CGRP− cell. Scale bar = 50 μm
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Potential roles for parvalbumin after nerve injury
PV is a calcium binding protein responsible for control-
ling the levels of intracellular calcium ions [60]. Calcium 
is vital for cell function and its concentration must be 
strictly regulated: too little and the cell cannot perform 
functions such as neurotransmitter release; too much and 
cellular mechanisms of apoptosis are triggered [61]. Sup-
port for PV’s ability to increase cell survival comes from 
animal studies of ALS pathogenesis. PV is only expressed 
in subsets of motoneurons such as Onuf ’s nucleus and 
the oculomotor nuclei [62–65], areas often spared from 
cell death in ALS patients. When PV was genetically 
overexpressed in motoneurons in vitro, they were better 
able to withstand concentrations of extracellular calcium 
associated with excitotoxic cell death and showed an 
increased ability to survive compared to their wild-type 
counterparts [66].
Peripheral nerve injury also causes cell death as a 
result of loss of trophic support [67, 68] that is differ-
entially distributed with respect to peripheral target, 
with a preference for loss of cutaneous versus muscle 
afferents [48, 69–71]. PV-ir cells are known to be trkC 
positive [12, 26] and levels of NT3 in peripheral tis-
sues are higher at birth then they are in the adult. It is 
possible that PV-ir cells maintain their trophic support 
from the CNS where levels are higher [72]. Supporting 
this, neonatal nerve crush depletes PV-ir cells from the 
DRGs [73]. Given that adult axotomy does not deplete 
neuronal p75 and that BDNF is upregulated in trkC neu-
rons [48, 55], it is probable that PV-ir cells are trophi-
cally supported by BDNF released from BDNF baskets 
that surround trkC cells containing p75 in an autocrine 
manner [51]. In contrast, injured small sized, cutaneous 
DRGs, lose p75 neuronal staining and do not upregulate 
BDNF after injury [10, 48] and so may be more vulner-
able to death.
Nerve injury also generates spontaneous and ectopic 
activity that is associated with axotomised and intact 
muscle, but not skin, afferents [39, 74, 75] that starts 
within hours, lasts many weeks and is predominantly 
associated with A-fibres. As PV-ir is associated with 
fast twitch muscles it is tempting to speculate that it is 
these fibres that may be spontaneously active in the DRG. 
However, electrophysiological data suggests that the 
very large-sized DRG cells are not spontaneously active 
[75]. As more than 80 % of axotomised muscle afferents 
express BDNF after injury [10] it is likely that many of 
the PV-ir afferents will express BDNF. Since BDNF is a 
potent neuromodulator of neuronal activity [76, 77], it is 
BDNF that is the major contributor to pain states from 
muscle afferents [10] whereas PV may be important 
for the survival of neurons after injury. An additional, 
or alternate, possibility is that spontaneous discharges 
may affect sensory processing through up-regulation of 
Nav1.7 in axotomised muscle afferents at the level of the 
gracile nucleus [56].
Conclusions
These results show that in two different models of 
peripheral nerve injury, the percentage of PV in DRG 
cells remains unchanged compared to naive or contralat-
eral DRGs. Furthermore, by using ATF3 as a marker of 
injured neurons and by using the spinal nerve ligation 
and section model [5, 34], they unequivocally demon-
strate, for the first time, that this is not the result of a phe-
notypic switch in expression from injured to uninjured 
cells, as numbers of PV-ir cells in the intact L4 DRG and 
the injured L5 DG remain unaltered. Therefore, PV posi-
tive afferents do not show the same phenotypic plastic-
ity that is characteristic of other neuronal subpopulations 
such as nociceptors [4, 46]. These results further high-
light the differential responses of muscle as compared to 
cutaneous afferents after peripheral nerve injury.
Methods
All experimental procedures were carried out in accord-
ance with the UK Scientific Procedures Act (1986) and 
guidelines set out by the International Association for the 
Study of Pain guidelines for the care and use of animals 
[78].
Surgery
Sixteen adult Wistar rats (250–350  g) were used and 
split into 3 groups: naive (n = 6), sciatic nerve axotomy 
(n = 5) and L5 spinal nerve ligation and section (n = 5). 
All surgical procedures were carried out on the left side 
under sterile conditions as described in detail previously 
[3, 43]. Briefly, the sciatic nerve was exposed at mid-thigh 
level, ligated with a 4-0 nylon suture and cut distal to the 
suture. For the spinal nerve injury, the L5 spinal nerve 
was exposed, ligated with a 4-0 nylon suture and the 
nerve cut distal to it. Following nerve section, the wound 
was closed and topical antibiotics applied to the wound 
site to prevent post-operative infection. All animals sur-
vived post-operatively for 2 weeks before perfusion.
Rats were terminally anaesthetised and perfused with 
saline followed by 4  % paraformaldehyde (dissolved in 
0.1  M phosphate buffer, pH7.4) fixative. The L4 and L5 
DRGs were removed bilaterally and post-fixed for 2  h 
before being cryoprotected overnight in 30  % sucrose 
dissolved in phosphate buffered saline (PBS) solution. 
Ganglia were embedded in OCT (VMR International) 
and frozen prior to sectioning for immunohistochemical 
staining.
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Immunocytochemistry
Longitudinal sections (8–10 µm) were cut on a cryostat 
and thaw-mounted onto Superfrost plus (VWR Inter-
national) slides. Each adjacent section was separated by 
50–100 µm. Sections were blocked in 10 % normal don-
key serum (Chemicon) for an hour and then incubated 
with goat anti-parvalbumin (1:8000, Swant, PVG214 
RRID:AB_10000345) for 24 h at room temperature. Slides 
were then washed 3 times in PBS before incubation with 
fluorescein isothiocyanate (FITC)-conjugated donkey 
anti-goat IgG (Jackson ImmunoResearch, 1:400) for 1 h.
In double labelling studies, sections were first incu-
bated in PV for 24  h, washed in PBS and then incu-
bated with rabbit anti-ATF3 (1:200, Santa Cruz SC-188 
RRID:AB_2258513), or rabbit anti-CGRP (1:2000, 
Affinity Research Products Ltd., UK) for 24–48  h at 
room temperature. Following three PBS washes, sec-
tions were then incubated in donkey anti-rabbit Cy3 
(1:800, Jackson ImmunoResearch, USA) for 2 h at room 
temperature. In some slides, sections were also coun-
terstained with 100  µg/ml DAPI (4,6-diamino-2-phe-
nylindole, Sigma, UK) to reveal neuronal nuclei. All 
slides were cover-slipped with 8:1 glycerol:PBS solu-
tion. Controls for double labelling included reversing 
the order of the antibodies or omission of the primary 
or secondary antibodies. The characteristics and valid-
ity of these antibodies have been described previously 
[5, 46, 79].
Slides were examined on a Leica fluorescence micro-
scope. For each animal, and each DRG, a minimum of 
500 neuronal profiles (cells with clearly visible nuclei, 
confirmed by DAPI staining) were counted from 3 to 5 
randomly chosen sections and the immunoreactivity (ir) 
was expressed as a percentage of all cells counted. PV-ir 
cells were considered positive if the intensity of staining 
was clearly above background staining seen in small-
sized neurons in the same section.
In double labelled sections, the percentage of PV-ir 
cells expressing either ATF3-ir or CGRP-ir was assessed 
by switching between the DAPI, FITC and TRITC filter 
blocks. Photographs were taken with a Hamamatsu digi-
tal C4742-95 camera and plates assembled using Adobe 
Photoshop v5. The quantification was performed in a 
non-blinded fashion, since levels of ATF3-IR would give 
clues to which group was being quantified.
Statistical analysis
All data is expressed as mean  ±  standard error of the 
mean. One-way ANOVA tests or independent samples 
t tests were carried out (using SPSS 16 statistical pack-
age, SPSS Inc., Chicago, IL, USA) to assess whether there 
was a statistically significant difference between groups; 
p < 0.05 was considered significantly different.
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